• About
  • Subscribe
  • Advertise
  • Contact
Friday, January 23, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

COVID-19 restrictions sparks Optometry Australia-Oculo partnership  

by rhiannon bowman
April 8, 2020
in Business, Company updates & acquisitions, Local, News
Reading Time: 2 mins read
A A
The ophthalmic sector is lobbying the government for telehealth Medicare items.

The ophthalmic sector is lobbying the government for telehealth Medicare items.

Share on FacebookShare on Twitter

Optometry Australia (OA) members will have access to Oculo’s telehealth platform, including its real-time videoconference feature, as part of a new partnership to ensure patients continue to receive optometric care during COVID-19.

Oculo and OA announced the new partnership on Tuesday 7 April which provides members’ access to Oculo for an initial six months to support optometrists’ telehealth capabilities.

Optometrists from Specsavers, Luxottica Australia, and Bupa Optical also use Oculo. Currently, OA, Specsavers and Luxottica are part of a group lobbying the government to allow eyecare professionals to deliver telehealth consultations under Medicare during COVID-19.

Kate Taylor, Oculo.

Oculo CEO and co-founder Dr Kate Taylor said the company was “delighted” to work with OA to ensure that Oculo’s platform for telehealth “supports as many eye health professionals and patients as possible at this difficult time”.

She added: “The Oculo platform enables optometrists to provide telehealth consultations minimising the need for in-person consultations which protects optometrists, staff and patients from infection with COVID-19 and for patients, assists in reducing the risk of preventable vision loss.”

OA CEO Ms Lyn Brodie said the organisation recognises the huge impact COVID-19 is having on its members.

“We want to do everything we can to protect the health of our members, their staff and their patients,” she said.

Lyn Brodie, Optometry Australia.

“During this pandemic, telehealth provides a great opportunity to ensure patients with eyecare needs that cannot be postponed, can access the optometric care they need.

“This is why we are supporting our members to access Oculo’s platform as it is a way of ensuring they have the systems they need to provide ongoing care to their patients.”

OA members are advised to update their member profile by midday AEST Thursday 9 April and flag if they or their practice are, or will, offer telehealth services, during the COVID-19 pandemic.

Oculo’s new videoconference feature went live last week for optometrists and ophthalmologists to continue delivering care to patients requiring ongoing support for chronic conditions.

Taylor told Insight that the company’s 11-strong development team had been working around the clock to implement the new feature for several weeks.

“The implication of cancelling significant amounts of routine outpatient activity are going to be felt long after the crisis phase of COVID-19 has passed,” Taylor said.

During the past fortnight, key industry stakeholders have lodged submissions with the Department of Health to modify optometry Medicare Benefits Schedule (MBS) item numbers 10916 (brief initial consultation) and 10918 (subsequent consultation) for telehealth purposes.

 

The Oculo platform has a new videoconference function that enables optometrists to provide telehealth consultations minimising the need for in-person consultations.
Tags: BupaCOVID-19Department of HealtheyecareLuxottica AustraliaMedicare Benefits ScheduleOculoOptometry AustraliaSpecsaverstelehealth

Related Posts

The most recent UK census data were used to obtain population counts stratified by age, sex and ethnicity. Image: Jennifer/stock.adobe.com

Glaucoma prevalence in UK far higher than estimated, new analysis shows

by Staff Writer
January 23, 2026

More than one million people in the UK are currently living with glaucoma, almost 50% higher than previous estimates, according...

The survey is a stocktake of the workforce in Australia, including occupation shortages. Image: buritora/Shutterstock.com.

Ophthalmic sector urged to share job-shortages survey

by Rob Mitchell
January 23, 2026

Chedy Kalach, a director and senior teacher at the Australasian College of Optical Dispensing, is urging everyone in the optical...

The investigational device combines ultra-widefield OCT with AI to enable rapid, non-invasive imaging of the retinas of premature infants. Image: Nenov Brothers/stock.adobe.com.

Handheld ultra-widefield OCT and AI system advances ROP diagnosis

by Staff Writer
January 22, 2026

Researchers at the OHSU Casey Eye Institute have developed the world’s first handheld ultra-widefield optical coherence tomography (OCT) system for...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited